"We are against the patent extension. According to the agreement, if a medicine is launched in the US, and then three years later it is launched in Malaysia, the patent would start from when it is launched here and not when it was launched earlier in the US," said Liow. "This is not fair."

--Datuk Seri Liow Tiong Lai, Malaysia Health Minister on the TPPA

Public Citizen's Analyses

Fact Sheet: How TPP Endangers Access to Medicines in Malaysia  August 2012   NEW!

Comparative Analysis of the U.S. IP proposal to the Trans-Pacific FTA and Malaysian Law

Other Documents

Bantah TPPA sends an open letter to Malaysian Cabinet Ministers on TPPA, August 2013

International AIDS Society: Statement from Françoise Barré Sinoussi and Chris Beyrer on the Trans-Pacific Partnership Agreement and Access to Medicines (TPP), July 2013 (links to

Joint statement from Malaysian health advocacy groups against the Trans-Pacific Partnership Agreement

MTAAG+ Memorandum to Human Rights Commission of Malaysia, February 2012 (link to

Malaysian Declaration on the Trans-Pacific FTA and Access to Medicines, September 2011

Consumer Association of Penang: Put a Hold on FTAs Unfavourable to US, December 2010 (link to

NGO Memo to MITI on EU-Malaysia FTA and TPP, December 2010 (link to

Round 10 of Trans-Pacific FTA negotiations, Kuala Lumpur, Malaysia

Partner Organizations in Malaysia

Malaysia AIDS Council

Third World Network

FTA Malaysia

Consumer Association of Penang

Positive Malaysian Treatment Access & Advocacy Group (MTAAG+)

PT Foundation, Malaysia

The TPP Will Also Affect Copyright Legislation and Internet Rights in Malaysia: Find out more

Back to Country Pages

Back to Trans-Pacific Partnership page

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.


To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.